VAERS reports by lot

Moderna COVID-19 lot AU3917B: VAERS reports

25 VAERS reports list lot AU3917B as a Moderna COVID-19 vaccine, received between 2023-10-18 and 2024-02-27. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
25
Reports
16%
Marked serious
2
With a death outcome
5
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological1325%
General / Systemic (non-local)1020%
Cardiac / Cardiovascular612%
Injection-site / Local reaction510%
Thrombotic / Hematological48%
Gastrointestinal48%
Dermatological (non-injection-site)48%
Reproductive / Menstrual36%
Allergic / Anaphylactic12%
Musculoskeletal12%

Where reports came from

U.S. state of the reporter, where given (top 12).

California5
Pennsylvania3
Connecticut3
Georgia2
Texas2
Ohio1
North Carolina1
Arizona1
Michigan1
Illinois1
Wisconsin1
Tennessee1

Reports by month received

2023-103
2023-1114
2023-121
2024-015
2024-022

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.